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Abstract
In fission yeast the intra-S phase and DNA damage checkpoints are activated in response to inhibition of DNA
replication or DNA damage, respectively. The intra-S phase checkpoint responds to stalled replication forks leading
to the activation of the Cds1 kinase that both delays cell cycle progression and stabilizes DNA replication forks. The
DNA damage checkpoint, that operates during the G2 phase of the cell cycle delays mitotic progression through
activation of the checkpoint kinase, Chk1. Delay of the cell cycle is believed to be essential to allow time for either
replication restart (in S phase) or DNA damage repair (in G2). Previously, our laboratory showed that fission yeast
cells deleted for the N-terminal half of DNA polymerase ε (Cdc20) are delayed in S phase, but surprisingly require
Chk1 rather than Cds1 to maintain cell viability. Several additional DNA replication mutants were then tested for
their dependency on Chk1 or Cds1 when grown under semi-permissive temperatures. We discovered that mutants
defective in DNA replication initiation are sensitive only to loss of Chk1, whilst mutations that inhibit DNA replica-
tion elongation are sensitive to loss of both Cds1 and Chk1. To confirm that the Chk1-sensitive, Cds1-insensitive
phenotype (rid phenotype) is specific to mutants defective in DNA replication initiation, we completed a genetic
screen for cell cycle mutants that require Chk1, but not Cds1 to maintain cell viability when grown at semi-permis-
sive temperatures. Our screen identified two mutants, rid1-1 and rid2-1, that are defective in Orc1 and Mcm4,
respectively. Both mutants show defects in DNA replication initiation consistent with our hypothesis that the rid
phenotype is replication initiation specific. In the case of Mcm4, the mutation has been mapped to a highly con-
served region of the protein that appears to be required for DNA replication initiation, but not elongation. There-
fore, we conclude that the cellular response to inhibition of DNA replication initiation is distinct from blocking
DNA replication elongation, and this difference can be exploited to identify mutants specifically defective in DNA
replication initiation.
Background
Assembly of DNA replication complexes begins in early
G1 following degradation of cyclin-dependent kinases at
the conclusion of mitosis [1]. The dramatic drop in
CDK activity following anaphase promotes the binding
of Mcm2-7 to origin DNA to form pre-replicative com-
plexes or pre-RCs. Formation of the pre-RC requires
both Cdc18/Cdc6 and Cdt1 proteins [2-4]. Once the
pre-RC is assembled, activation of CDK (cyclin depen-
dent kinase) and DDK (Dbf4-dependent kinase) at the
beginning of S phase leads to the binding of additional
replication proteins to origin DNA including DNA poly-
merase epsilon, Sld2, Sld3, Cdc45, and GINS forming
the pre-initiation complex or pre-IC [5,6]. Binding of
DNA polymerase alpha is then required to allow synth-
esis of short primers that are then extended during S
phase by DNA polymerase delta [7-10].
DDK and CDK are two serine kinases required for the
onset of S phase. They target components of the pre-RC
and pre-IC, respectively and are essential for initiation
of DNA replication. It is believed that structural modifi-
cations to the pre-RC stimulated by DDK activity leads
to Cdc45 binding to the MCM complex stimulating its
helicase activity [11]. Following the partial unwinding of
DNA, CDK then targets two proteins, Sld2 and Sld3,
promoting the assembly of the pre-IC and ultimately the
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unique in that it appears to function both in the initia-
tion of DNA replication ie. during formation of the pre-
RC, as well as in DNA replication elongation as the
putative DNA helicase [11,14]. These two functions
appear to be separable, since Mcm mutants defective in
DNA replication elongation are still capable of binding
chromatin and presumably establishing the pre-RC [15].
Mcm proteins contain ATP binding sites but ATP
hydrolysis is only required for replication elongation and
not for chromatin binding [15].
When DNA replication is blocked by either addition
of inhibitors such as hydroxyurea or by DNA damage, a
checkpoint control ensures that mitotic entry is delayed
and that replication complexes are stabilized [16,17]. In
fission yeast, this checkpoint, called the intra-S phase
checkpoint requires several proteins encoded by the rad,
hus1, mrc1 and cds1 genes. Although Cds1 delays cell
cycle progression by phosphorylating and inhibiting the
Cdc25 phosphatase [18,19], its most critical role for
maintaining cell viability is to stabilize stalled replication
complexes [20-22]. In the absence of Cds1, cells lose
viability rapidly upon inhibition of DNA replication
elongation, and this decrease in viability is not the result
of cells entering mitosis prematurely. On the other
hand, DNA damage during G2 leads to the activation of
a distinct checkpoint that is also dependent on the
expression of the rad and hus1 genes, but requires a
unique adaptor protein Crb2, and the effector kinase
Chk1 [23,24]. Chk1 maintains cell viability by preventing
premature entry into mitosis by directly phosphorylating
and inhibiting Cdc25 [24].
Previously, our lab reported that cells deleted for the
N-terminal half of DNA polymerase ε catalytic subunit
(Cdc20) are viable, but have a significant S phase delay
[25]. Although we expected that this delay would be due
to activation of the intra-S phase checkpoint, we were
surprised to find that these cells require Chk1, but not
Cds1 to maintain cell viability. Our hypothesis was that
the Chk1 dependency, Cds1-independency of the DNA
polymerase epsilon mutant reflected a unique role for
this polymerase in the assembly of the pre-IC. We
therefore tested several other DNA replication tempera-
ture-sensitive (ts) mutants for their sensitivity to the loss
of either Cds1 or Chk1 when grown under semi-permis-
sive conditions. Our results suggest that mutants defec-
tive in DNA replication initiation (referred to as rid
mutants) require the checkpoint kinase Chk1 for viabi-
lity, while those defective in the elongation step
(referred to as red mutants) require Cds1 [26]. To test
our hypothesis further we have now completed a genetic
screen for cell division cycle (cdc) mutants that are sen-
sitive to the loss of Chk1, but not Cds1. This screen
identified novel mutant alleles of cdc30/orp1 and cdc21/
mcm4, two proteins that are essential for DNA replica-
tion initiation. Consistent with the screen being specific
for initiation mutants we find that the mutation identi-
fied in Mcm4, which maps to a highly conserved region
within the central MCM domain signature motif III
(http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?-e+[prints-
AccNumber:PR01657), disrupts only its initiation func-
tion, whilst leaving its putative elongation function
intact. Our results demonstrate that the rid mutant phe-
notype provides a powerful tool to identify mutants
defective in the DNA replication initiation, and that the
cellular response to inhibition of DNA replication initia-
tion is distinct from the response to blocking DNA
replication elongation.
Results
Replication initiation (rid) mutants have unique
checkpoint requirements
Previously, we showed that several mutants defective in
DNA replication initiation are sensitive to the loss of
chk1
+,b u tn o tcds1
+ [26], see also Additional file 1,
Table S1. In contrast, the viability of DNA replication
elongation mutants was severely compromised in the
a b s e n c eo fe i t h e rC d s 1o rC hk1 when grown at semi-
permissive temperatures. We hypothesized that the
Chk1-dependent, Cds1-independent phenotype is
unique to replication initiation mutants and could be
exploited in a genetic screen to identify mutants specifi-
cally defective in DNA replication initiation.
Developing a screen for rid mutants
The strategy for our genetic screen to identify DNA
replication initiation mutants is outlined in Figure 1A.
First, we randomly mutagenized cells with nitrosoguani-
dine and screened for mutants that displayed a cell cycle
delay (indicated by an elongated cell phenotype) when
shifted to the restrictive temperature of 36°C. In our
initial screen, the Δcds1 strain was used for mutagenesis
to avoid isolating mutants that were defective in DNA
replication elongation and thus sensitive to loss of Cds1.
Selected mutants that displayed the cdc (cell division
cycle) phenotype were backcrossed to wild-type cells
several times to eliminate the background Δcds1 and
confirm that the mutation had occurred in a single
gene. Each putative rid mutant was then crossed to
either the Δcds1 or Δchk1 strain to generate double
mutants. Using a serial dilution spot assay, the viability
of the double mutants was then compared to both wild-
type cells (wt) and the three parental single mutant
strains (putative rid mutant, Δchk1 and Δcds1) at several
different temperatures. Mutants that showed a selective
loss of viability in the absence of Chk1, but not Cds1 as
the temperature was increased were selected as potential
rid mutants (Figure 1B). From approximately 70,000
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were isolated, of which 56 displayed the cdc phenotype
upon temperature shift. Only two mutants, rid1-1 and
rid2-1, displayed the rid phenotype ie. cdc phenotype
and loss of viability in the absence of Chk1 while retain-
ing viability in the absence of Cds1 as shown in Figure
1B. In the case of rid2-1,w ew e r eu n a b l et oi s o l a t e
viable rid2-1Δchk1 double mutants at 25°C suggesting
that rid2-1 is defective in DNA replication initiation
even at this lower temperature. In the absence of chk1,
rid2-1 mutants are only capable of forming small colo-
nies of 4-8 cells, and many of these cells display the cut
phenotype, indicating that cells have entered mitosis in
the absence of a complete round of DNA synthesis [27].
Identification of rid1-1 and rid2-1 as novel alleles of
cdc30/orc1 and cdc21/mcm4
To identify the genes mutated in both rid1-1 and rid2-1
we transformed both mutants with a variety of plasmids
expressing genes known to be essential for DNA replica-
tion. A plasmid expressing the cdc30/orc1+ gene rescued
the ts cdc phenotype of rid1-1 (Figure 2A), and a plas-
mid expressing cdc21
+/mcm4
+ rescued rid2-1 (Figure
2B). Integration of the gene expressing orc1
+ (in the
rid1-1 strain) and mcm4
+ (in the rid2-1 strain) showed
that the gene was closely linked to the mutation, sug-
gesting that rid1-1 and rid2-1 encode orc1
+ and mcm4
+
respectively (data not shown). To confirm the results of
our complementation analysis, we isolated genomic
DNA from rid1-1 and rid2-1, and cloned and sequenced
the cdc30 and mcm4 genes, respectively. For rid1-1 we
identified a single point mutation, G2061A that corre-
sponds to an amino acid change from glycine to aspartic
acid at position 670 in the Orc1 protein (Figure 2C). For
rid2-1, we identified a point mutation, G1541A, corre-
sponding to a change from glycine to glutamate at posi-
tion 514 in Mcm4 (Figure 2D). The rid1-1 mutation is
located at the C-terminus of the Orc1 protein, outside
of any functional domain previously reported for this
protein and downstream of the AAA ATPase domain.
The mutation identified in Mcm4 resides in the central
MCM domain, within the Mcm4 signature motif III, a
highly conserved region of the protein (Figure 2E). No
specific function has yet been ascribed to this domain.
This mutation is adjacent to but not within the ATP
binding Walker A motif that has been suspected of
being required for MCM-associated helicase activity
[28,29].
The phenotype of the two rid mutants suggests defects
in DNA synthesis
Both mutants display a cdc phenotype and eventually
arrest with a single nucleus when grown at the non-per-
missive temperature of 36°C (Figure 3A). For rid2-1,
Figure 1 Isolation of rid mutants. (A) Strategy for identification or replication initiation defective (rid) mutants, see methods for details. (B) Left
panel, serial dilution of rid1-1 at the semi-permissive temperature of 29°C, Right panel, serial dilution of rid2-1 at the semi-permissive
temperature of 33°C. The mutant rid2-1Δchk1 is not shown because it was found to be non-viable at 25°C.
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containing the orc1
+ gene or no orc1
+ (empty). Only those cells transformed with orc1
+ containing DNA were capable of growing at the
restrictive temperature of 36°C. (B) Wildtype or rid2-1 cells were transformed with plasmid DNA containing mcm4
+ or no mcm4
+ (empty). Only
cells transformed with mcm4
+ DNA were capable of growing at 36°C. (C) Schematic diagram of rid1-1 showing the position of the mutation in
the C-terminal portion of Orc1. (D) Schematic diagram of rid2-1 showing the position of the mutation in Mcm4 signature motif III, relative to the
Walker A and Walker B binding motifs. The number 509 corresponds to the first amino acid position for motif III. The Mcm4 signature motifs are
10-12 amino acids long. (E) Sequence comparison of motif III from various organisms including human indicating strong evolutionary
conservation for this region of the protein. The position of the rid2-1 mutation is shown.
Figure 3 Phenotype of rid mutants at restrictive temperature.( A )rid1-1 and rid2-1 show slight elongation when shifted to the semi-
permissive temperature, suggesting a cell cycle delay. (B) Flow cytometry analysis of rid1-1 and rid2-1 following shift to restrictive temperature of
36°C. Cells accumulate with 1C DNA content following shift of rid1-1 to 36°C (150-180 mins post-shift) whilst rid2-1 shows very little change in
DNA content.
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elongated when compared to wild-type cells consistent
with our observation that Chk1 is required for viability
even at this lower temperature. Upon shift to the
restrictive temperature, analysis of DNA content by flow
cytometry demonstrates that rid1-1 displays a shift
towards 1C DNA content during the first two hours
showing significant accumulation of cell is S phase at
longer times. The mutant rid2-1 displays a broad peak
at 25°C suggesting that cells are already delayed in
S phase at the permissive temperature consistent with
the observed elongated phenotype and sensitivity to loss
of Chk1 at this temperature. Therefore, although both
mutants are likely to have problems completing S phase,
we conclude that neither of these mutants display a
robust defect in replication initiation. We suspect that
the observed S phase delay and activation of Chk1 are
caused by either DNA damage that arises from collisions
of replication forks with non-fired origins or from mis-
assembly of replication initiation complexes. We
hypothesize that this partial block to initiation that
results from a failure to assemble the proper number of
initiation complexes can ultimately inhibit fork progres-
sion and generate DNA damage related structures that
can activate Chk1. It is important to point out that this
scenario is presumed to be distinct from the Cds1-
dependent checkpoint that responds to more extensive
inhibition of DNA replication elongation as is observed
in mutants defective in DNA polymerase delta (cdc6,
cdc27) or in cells grown in the presence of hydroxyurea.
Chk1 activation in rid1-1 and rid2-1 mutants
Previous experiments in our lab showed that in addition
to Chk1 being required for the viability of rid mutants
grown at elevated temperatures, chk1 was also activated
in these mutants [26]. Therefore we monitored Chk1
activation in the rid1-1 and rid2-1 mutants by assaying
for the presence of the slower migrating phosphorylated
form of Chk1 by western immuno-blotting at elevated
temperatures. For these experiments cells containing
H A - t a g g e dC h k 1w e r ec r o s s e dt oe a c ho ft h et w o
mutant strains to generate rid1-1 and rid2-1 strains con-
taining HA-Chk1 in place of wild-type Chk1. Exponen-
tially growing cultures of these two mutant strains were
shifted to their respective semi-permissive temperature
for two hours, and cells were then harvested, protein
extracts prepared and analyzed for Chk1 protein by wes-
tern blotting using HA antibodies (Figure 4A). In both
rid1-1 and rid2-1, the appearance of the Chk1-phos-
phorylated protein confirms that Chk1 is activated in
these mutants at the elevated temperature. Not surpris-
ingly, Chk1 is also phosphorylated in rid2-1 at 25°C,
consistent with its sensitivity to the loss of Chk1 at this
temperature.
Mrc1 is required in rid1-1 and rid2-1 mutants
Our analysis of other rid mutants has demonstrated that
their viability is not only dependent on Chk1, but also
requires Mrc1 [30-34]. These experiments revealed a
function for Mrc1 that is independent of its role in acti-
vation of the intra-S phase checkpoint. We confirmed
that the viability of rid1-1 and rid2-1 strains is also
dependent on expression of Mrc1 (Figure 4B). As was
observed for Δchk1, no viable double mutants contain-
ing rid2-1 and deletion of mrc1 c o u l db eo b t a i n e da t
25°C. Consistent with our previous findings regarding
initiation mutants, we also found that rid1-1 or rid2-1
were not hypersensitive to hydroxyurea (Figure 4C).
The mutant rid2-1 is defective in DNA replication
initiation, but not elongation
We hypothesized that the rid mutant phenotype is spe-
cific for mutants defective in DNA replication initiation
and is not associated with mutants defective in DNA
replication elongation. The fact that our genetic screen
yielded two mutants defective in proteins required for
DNA replication initiation provides compelling evidence
that our hypothesis is correct. However, rid2-1 encodes
Mcm4, a protein that has also implicated in DNA repli-
cation elongation [14]. With the exception of a Mcm-
degron mutant that was used to confirm the role of
Mcms in replication elongation, all other conditional
mcm mutants isolated so far have displayed defects only
in DNA replication initiation. Nevertheless, we set out
to test whether rid2-1 has defects in either DNA replica-
tion initiation or elongation using a hydroxyurea block
and release experimental approach (Figure 5A). Our
strategy was to release the rid2-1 mutant from a hydro-
xyurea block at either the semi-permissive temperature
(as defined in Materials and Methods) of 25°C or at the
higher temperature of 33°C. Considering that HU inhi-
bits DNA replication during the early stages of DNA
replication elongation, mutants defective in DNA repli-
cation initiation should have no discernable delay in cell
cycle progression during the first cell cycle after release
from HU. However, a G1/S delay should be observed as
cells complete mitosis and enter the subsequent cell
cycle. In contrast, mutants defective in DNA replication
elongation should display an immediate delay in cell
cycle progression upon release from HU. We hypothe-
sized that if shifting the temperature from 25°C to 33°C
only affects initiation in the rid2-1 mutant, then cell
division rates should not change as a function of tem-
perature during the first cell division following release,
but as cells enter the subsequent cell cycle, the doubling
time should significantly increase at the higher tempera-
ture of 33°C.
At 25°C, rid2-1 has a cell cycle time nearly double that
of wild-type cells that was further increased by
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complete cell cycles following HU block and release, we
needed to extend the time-course following release to
24 hrs. For controls, we examined the cell cycle timing
for wild-type cells and for the DNA replication initiation
mutant cdc20 (encoding DNA polymerase epsilon), and
the DNA replication elongation mutant, cdc27 (encoding
a subunit of DNA polymerase delta) at permissive (wt,
cdc20, cdc27), semi-permissive (wt), or non-permissive
temperatures (cdc20 and cdc27). To demonstrate the
expected phenotype for initiation and elongation
mutants following HU block and releases, cdc20 and
cdc27 cells were grown at 25°C and treated with HU to
arrest cells in early S phase. Cells were then shifted to
the non-permissive temperature of 36°C for 1 hr prior
to release from HU. Cells defective in DNA polymerase
epsilon (cdc20) divided once before arresting in the sub-
sequent cell cycle (Figure 5B, open squares). This phe-
notype is consistent with cdc20 cells being defective in
DNA replication initiation. In contrast, cdc27 cells that
Figure 4 Chk1 is activated in rid1-1 and rid2-1. (A) Chk1 phosphorylation occurs in both rid1-1 and rid2-1 strains at 29°C and 25°C,
respectively. (B) rid1-1 viability is dependent on expression of mrc1
+ (C) rid1-1 and rid2-1 are not hypersensitive to hydroxyurea treatment as
compared to Δmrc1.
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divide, and arrest with an elongated cell phenotype con-
sistent with DNA replication being blocked immediately
following release from HU (Figure 5B, open triangles).
For the experiments involving wt cells and rid2-1, cells
w e r ef i r s tg r o w no v e r n i g h ta tt h ep e r m i s s i v et e m p e r a -
ture of 25°C and HU was added for 4 hours to arrest
cells in early S phase. Prior to release from HU, half of
the cells were shifted to the higher temperature of 33°C
while the other half was kept at 25°C. Cells were then
filtered and washed with pre-warmed media (25°C or
33°C), and re-suspended in fresh media containing no
HU. Cell number was then monitored every hour for
approximately 24hrs (or 12 hrs for the wt control). As
expected, we found that wild-type cells doubled in
approximately 5 hrs (a delay attributable to the HU
treatment) and quickly returned to the normal cell cycle
time of approximately 2-2.5 hrs during subsequent cell
divisions (Figure 5C, open squares). As expected, at
25°C, wt cells have a generation time approximately
Figure 5 The rid2-1 mutant displays a DNA replication initiation defect. (A) Experimental Strategy. See Text for a description of the
experimental design for the hydroxyurea block and release experiment. (B) Control experiment showing the behavior of two different mutants
known to be defective in DNA replication initiation (cdc20) and DNA replication elongation (cdc27). The cdc20 mutant completes cell division on
schedule and doubles following release from HU. As expected for an initiation mutant, no increase in cell number is observed during the
second cell cycle period. On the other hand, mutants defective in replication elongation (cdc27) show no significant increase in cell number
throughout the course of the experiment. (C) Following release from the HU block wildtype cells show normal cell cycle kinetics. The first cell
division or population doubling occurs at 4 hrs (33°C) and 6 hrs (25°C) that are longer than normal due to the time needed for recovery from
HU. All subsequent cell cycles occur with normal kinetics for the indicated temperatures and are approximately 2 hrs at 33°C and 4 hrs at 25°C.
The mutant rid2-1 grows slowly and requires at least 10 hours for the first population doubling which is not effected by shifting cells to the
semi-permissive temperature of 33°C. However, during the second cell cycle period, rid2-1 cells at 33°C have a significant cell cycle delay as
compared to cells that remain at 25°C, suggesting that DNA replication initiation is defective in these mutants.
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33°C (Figure 5C, filled squares). Interestingly, for rid2-1,
no significant cell cycle delay is observed following
release from HU at the higher temperature of 33°C (Fig-
ure 5C, open triangles) when compared to cells released
at the lower temperature of 25°C (Figure 5C, filled trian-
gles), consistent with rid2-1 having a negligible effect on
DNA replication elongation. However, a strong cell
cycle delay is observed for rid2-1 cells at 33°C during
the subsequent cell cycle. Whereas at 25°C, rid2-1 com-
pletes the second cell doubling at approximately 15 hrs,
at 33°C, cell division does not occur until approximately
24 hrs. Therefore, these results are consistent with rid2-
1 having a significant defect in DNA replication initia-
tion, whilst having little or no effect on DNA replication
elongation, as predicted on the basis of its checkpoint
phenotype.
Discussion
In this report we have shown that mutants defective for
DNA replication initiation require Chk1, but not Cds1
to maintain cell viability. We refer to this phenotype as
the rid phenotype (for replication initiation defective).
In contrast, the viability of mutants defective in DNA
replication elongation ie. cdc6, cdc27, is dependent on
the checkpoint kinase Cds1. We conducted a genetic
screen for mutants that display the rid phenotype and
isolated two mutants, rid1-1 and rid2-1. Sequencing
confirmed that these mutants contain point mutations
in two initiation proteins, Orc1 and Mcm4, respectively.
These data are consistent with our screen being highly
selective for the isolation of mutants specifically defec-
tive in DNA replication initiation. This implies that the
cellular response to blocking DNA replication initiation
is distinct from the cellular response to inhibiting DNA
replication elongation. We have also found that
although Cds1 is not essential in mutants defective in
DNA replication initiation, the observed dependency on
Mrc1 suggests a novel role for this protein in the stabili-
zation of replication forks when initiation is impaired.
Mrc1 was originally discovered in both fission yeast and
budding yeast as a protein that mediates the activation
of Cds1 (Rad53 in S. cerevisiae)a ts t a l l e dr e p l i c a t i o n
forks [35-37]. The orthologous protein, Claspin, has a
similar role in animal cells [38-41]. Mrc1 has also been
shown to be a part of a protein complex that associates
with unperturbed replication forks and is believed to
have a role in both the stabilization of DNA replication
complexes and the coupling of the MCM helicase to
DNA polymerase epsilon [5,42-45]. Still other reports
suggest that Mrc1 has a role in sister chromatid cohe-
sion [46,47], and telomere capping [48-50]. Based on
our analysis of Chk1 activation in rid mutants in the
a b s e n c eo fM r c 1w eb e l i e v et h a tM r c 1h a sn or o l ei n
checkpoint signaling in response to replication initiation
defects. However, the dependency of rid mutant viability
on the presence of Mrc1 strongly argues that the normal
replication function(s) of Mrc1 are essential in mutants
defective in DNA replication initiation. It is not yet
clear whether this reflects its putative role in replication
fork stabilization, coupling of the helicase to DNA poly-
merase or to some other yet unidentified replication
function. Moreover, Mrc1 is known to form a complex
with at least two additional proteins, Swi1 and Swi3,
that could directly interact with the initiation complex
and potentially regulate its activity [34,51].
The role of Chk1 in maintaining the viability of rid
mutants is likely to be its function in delaying the onset
of mitosis, however we cannot exclude the possibility
that Chk1 might have an additional function in directly
stabilizing forks as has been recently observed in S. cere-
visiae mutants lacking RAD53 and EXO1 [52].
In rid2-1, the mutation in Mcm4 resides in a highly
conserved region of the protein called domain 4 of the
MCM central homology region. No specific function has
been attributed to this region of the protein that lies
just outside but adjacent to the Walker A and Walker B
motifs that are believed to bind ATP and be important
MCM helicase activity [53]. Based on our analysis of the
rid2-1 mutant, we suggest that this mutation results in a
specific defect in DNA replication initiation, but has lit-
tle effect on the presumed function of Mcms in DNA
replication elongation. Consistent with this hypothesis,
rid2-1 shows normal cell cycle kinetics of DNA replica-
tion following release from an early S phase arrest
imposed by treatment with hydroxyurea. Therefore,
although Mcm proteins are required for both DNA
replication initiation and elongation, the data is consis-
tent with rid2-1 having defects only in its initiation
function. With the exception of the degron mutants of
Mcm4, which were specifically designed to test the role
of Mcms in replication elongation, our results are simi-
lar to those reported for mcm mutants in S. cerevisiae
and S. pombe that display no obvious defects in DNA
replication elongation. In the case of Orc1, it is generally
agreed that Orc1’s primary role in DNA replication is to
establish pre-RCs at the conclusion of mitosis, and
therefore in this case, our screen has led to the identifi-
cation of a bona-fide initiation protein. This of course
does not exclude the possibility that Orc1 might have
additional cellular functions outside of DNA replication,
as has been recently reported for human Orc1 [54]. The
mutation in rid1-1 lies in the C-terminal portion of the
protein in a region that has yet to be fully characterized.
Understanding the molecular events that lead to the
initiation of DNA replication has been a central ques-
tion for cell biologists for several decades. Recently, sev-
eral reports have suggested that mutations in the genes
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instability and cancer. In particular, mutations in
MCM4 in mice can lead to increased frequency of
sporadic tumors [55]. Moreover, several lines of research
have suggested that Mcm proteins might provide impor-
tant diagnostic markers for early detection of cancer
[56-59]. Finally, inhibition of DNA replication might
provide an attractive therapeutic strategy for the treat-
ment of cancer, because recent studies have shown that
tumor cell lines might be selectively sensitive to inhibi-
tion of DNA replication initiation [60-62].
While all previous evidence is consistent with Orc1
having a function in the initiation step of the DNA
synthesis, studies on Mcm proteins, including Mcm4,
support a dual function during replication, both during
the initiation and the elongation stages. Mcm4 was
found to interact with ORC components, Cdc18 and
Cdc45, as well as with the other MCM complex compo-
nents (11, 34-37). Mcm4 can be isolated as a heterotri-
meric complex with Mcm6 and 7, also known as “the
core MCM”, that possesses in vitro helicase activity and
is required for the proper formation of the heterohexa-
meric MCM 2-7 complex (36, 37). Structurally, Mcm4,
and all other Mcm subunits, have a central region of
homology, known as the MCM domain. In this region,
there are the consensus Walker A and B ATPase motifs
which are required for nucleotide binding and ATPase
activity. Therefore this domain is likely to be responsible
for the putative helicase activity of the MCM complex
(38-41).
The N-terminal region of Mcm4 presents several
putative CDK-phosphorylation sites. Mutational analysis
in Xenopus and S. pombe suggested that phosphoryla-
tion of these sites are important for the helicase activity
regulation and prevention of re-replication [63-65].
Alignment of several Mcm4 molecules from diverse
eukaryote systems showed that the G514E mutation in
rid2-1 affects a small but very conserved sequence cen-
trally located (in the MCM domain), about 40 amino-
acids upstream of the Walker A motif. The G514E
mutation lies in the third of five Mcm4 signature motifs
that currently has no known function. The high degree
of conservation in these signature motifs in many eukar-
yotes suggests an important yet not determined role for
this region of the protein. Further work will be needed
to fully understand how the mutation in rid2-1 can inhi-
bit initiation of DNA replication. Here we provide a
powerful genetic tool for the isolation of mutants defec-
tive in DNA replication initiation that should be helpful
in identifying new genes required for initiation, as well
as hypomorphic alleles of known initiation proteins that




All strains used in this study were derived from wildtype
972h- and 975h+. All genetic manipulations were per-
formed as previously described [66].
Nitosoguanidine mutagenesis
Approximately 10
8 exponentially growing wildtype or
Δcds1 cells were treated with nitrosoguanidine at a final
concentration of 0.15 mg/ml. Aliquots of 10
7 cells were
harvested at different times (0, 5, 10, 15, 20, 30, 45, 60
and 90 minutes) after treatment, were washed three
times in Tris-maleate buffer pH6, once in YE and then
resuspended in 1 ml YE and incubated at 25°C for four
hours to allow recovery. Cells were counted and
approximately1000 cells were plated in triplicate for
each time-point and incubated at 25°C. After several
days, the colonies arising on each plate were counted
and a survival curve was plotted. Time 0 was presumed
to represent 100% survival. For screening, cells from the
5 minute time-point (representing 50% survival) were
plated on rich media plates at a density of approxi-
mately 2000 cells per plate and incubated at 25°C until
colonies formed. To screen individual colonies for the
cell division cycle (cdc) phenotype, colonies were
replica-plated to YE plates containing phloxine B (a vital
stain) and incubated at the elevated temperature of
36°C. The temperature-sensitive (ts) colonies (deter-
mined by their dark pink staining) were analyzed micro-
scopically and the colonies displaying the cdc or
elongated cell phenotype were selected as putative rid
mutants.
Construction of double mutants
Double mutants were generated using standard proce-
dures [66]. Briefly, cells of different mating types
(h
+ and h
-), were mixed on malt extract (ME) plates and
incubated at 25°C for 2-3 days. Mature asci were then
suspended in 1 ml sterile H2O. 5 μl of glusulase were
added to the suspension and incubated overnight at
25°C, to allow digestion of the asci walls and to kill all
vegetative cells. Spores were then washed twice with
sterile H2O, plated at a density of 500 spores/plate on
rich media (YE) plates and incubated at 25°C to allow
spore germination and colony formation. Double
mutants were identified after replica plating to confirm
the presence of specific markers or phenotypes.
Viability test (synthetic lethality assessment)
Exponentially growing cultures (OD595 = 0.2 - 0.4) for
each strain to be analyzed were adjusted to a density of
10
7 cells/ml that were then subjected to at least 5 rounds
of a 5-fold serial dilution. For each strain, 5 μl of each
Locovei et al. Cell Division 2010, 5:20
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Page 9 of 12diluted sample were spotted on YE plates from most
concentrated to least concentrated. Plates were incu-
bated at the indicated temperature (ranging between 25
to 36°C) for 4-7 days, or for the amount of time neces-
sary to determine differences between the viability of
the strains being tested. For this study, the semi-permis-
sive temperature is defined as the temperature where
the single ts mutant in the presence or absence of cds1
+
is viable, but is sick or inviable in the absence of chk1
+.
Hydroxyurea sensitivity test
Cultures were prepared for each strain as described for
the viability experiment. Spots were plated on YE plates
containing 0, 2, 5, 7.5, and 10 mM HU, and plates were
incubated at temperatures ranging from 25 to 36°C for
4-5 days, and colony formation was assessed.
Fixing cells for flow cytometry
Cells were harvested by centrifugation at 5000 g for
5 mins, washed once with sterile H2O, and re-suspended
in 1 ml cold 70% ethanol. For flow cytometry analysis,
0.2 ml of cells in ethanol were centrifuged and re-sus-
pended in re-hydration buffer (50 mM Na citrate con-
taining 0.1 mg/ml RNAase A) and incubated at 37°C for
2 hours. Sytox green (Molecular Probes) was then added
to a final concentration of 2 μm prior to analysis.
Fission yeast transformation
Exponentially growing cells (OD595 = 0.2-0.5) were har-
vested, washed once with sterile water, re-suspended at
ad e n s i t yo f1 0
9 cells/ml in 0.1 M lithium acetate (pH
4.9) and dispensed in 100 μl aliquots into Eppendorf
tubes. Cells were incubated at 25°C for 60 - 120 min-
utes. 1 μg of plasmid DNA in 15 μl TE (pH 7.5) was
added to each aliquot and mixed, followed by the addi-
tion of 290 μl of 50% (w/v) PEG 4000, mixing and incu-
bation at 25°C for 60 minutes. Cells were heat shocked
at 43°C for 15 minutes. Tubes were cooled to room
temperature for 10 minutes, and then cells were har-
vested by centrifugation, and re-suspended in 1 ml of 1/
2 YE broth. The suspension was transferred to a 50 ml
flask and diluted with 9 ml of 1/2 YE, followed by
recovery at 25°C for 60 minutes. Cells were then con-
centrated in 1 ml of ½ YE and 100 ul aliquots were pla-
ted on selective agar plates.
Cloning of rid1-1 and rid2-1 mutated genes
Genomic DNA extraction from rid1-1 and rid2-1 strains:
rid1-1 and rid2-1 liquid cultures were grown to station-
ary phase. Cells were harvested, re-suspended in 50 mM
citrate/phosphate pH 5.6 40 mM EDTA pH 8.0 1.2 M
sorbitol, followed by the addition of Zymolase and incu-
bated at 37°C for 30-60 minutes. The cells were then
pelleted briefly and resuspended in TE buffer 1% SDS
and incubated at 65°C for 1 hr. 5 M potassium acetate
was added, and the tube was kept on ice for 5 minutes.
The resulting suspension was centrifuged at 12000 rpm
for 15 minutes at 4°C, the supernatant was collected
and the DNA was precipitated by addition of cold iso-
propanol and incubation at -20°C for 10 minutes. The
tube was then centrifuged for 15 minutes at 4°C. The
supernatant was discarded and the pellet was washed
with 70% ETOH. The pellet was resuspended in TE buf-
fer containing 50 μg/ml RNAse A and incubated at 65°C
for 10 minutes. Two rounds of phenol/chloroform
extraction were performed, followed by 3 M sodium
acetate and cold 100% ethanol precipitation of DNA on
ice for 10 minutes. The DNA was pelleted by centrifuga-
tion at 10000 rpm for 10 minutes, washed with 70%
ETOH and dried at 37°C. The last step was the resus-
pension of genomic DNA in TE buffer containing
RNAse A and incubating for 5 minutes at 37°C.
Primer design: The primers used for PCR amplification
of the entire cdc21/mcm4 and cdc30/orp1 open reading
frames were:
mcm4 XhoI-F: 5′ CCGCTCGAGCGGTCTTTCTA-
CACCCACCACGAG 3′






Cloning rid1-1 and rid2-1 in pCR Blunt vector: PCR
amplification of rid1-1 (mutated cdc30/orp1 gene) and
rid2-1 (mutated cdc21/mcm4 gene) was completed using
the above primers and genomic DNA extracted using
rid1-1 and rid2-1 strains as the template DNA. After
checking the proper band size on a 0.8% agarose gel, the
ligation was performed directly from the PCR product
into a pCR-Blunt vector (Invitrogen Topo-Blunt kit).
Sequencing the rid1 (cdc30/orp1) and rid2 (cdc21/mcm4)
gene
Primer design: Additional forward and reverse primers
were designed for cdc30 and cdc21, spanning the entire









Locovei et al. Cell Division 2010, 5:20
http://www.celldiv.com/content/5/1/20






Other primers used were the M13 forward and reverse
primers existing in the pCR-Blunt vector, flanking the
cloning sites.
Sequencing and data analysis: Cloned DNA from each
mutant were sequenced and aligned with the wildtype
cdc30
+ and cdc21
+ sequences using the Clone Manager
Suite 7 software to identify the site of the mutations in
rid1-1 and rid2-1. The same software was used to trans-
late and compare the amino acid sequences of wildtype
and mutant Orc1 and Cdc21 proteins.
HU block-release
Exponentially growing cultures were treated with
12 mM HU for 4 hours, followed by HU wash by filtra-
tion under vacuum on Millipore membranes, with
media warmed to the temperature to be used for shift.
For each experiment, after wash, cells were shifted to
the indicated temperatures, and aliquots were collected
every 30 minutes for cell counting. The length of tem-
perature exposure depended on the time needed for wt
(used as control for each experiment and every tempera-
ture tested) and mutant strains to undergo two com-
plete rounds of cell division. Samples were fixed in
formal saline and then the number of cells in a fixed
volume was counted using Sysmex K-1000, in triplicate,
for each sample.
Additional material
Additional file 1: S. pombe mutants tested for rid phenotype.
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